News Center

Home page

Peak Report

News reports

The company held the fourth session of the 11th board of directors and the fourth session of the 10th board of supervisors to examine and approve the 2021 semi-annual report and other motions.

Release time:

2021-09-13

News from our newspaper # February 27 , the company held the fourth meeting of the 11th board of directors to review and approve 2021 semi-annual report and its summary, the proposal on the disposal of assets by the holding subsidiary, the proposal on the appointment of the director of the audit office, the proposal on the related party transaction proposal on the signing of the framework agreement on the equity restructuring of the participating subsidiary and other 4 related reports and proposals.

2021# In the first half of the year, the company focused on the general policy of "following the law, keeping the right and bringing forth the new, changing and innovating, and continuously improving", on the basis of risk prevention and control, optimize the management system, improve operational efficiency, and maintain the smooth operation of the company. In the first half of the year, the company realized operating income

17.13 .3 billion yuan, net profit 3.20 .5 billion yuan attributable to shareholders, and earnings per share 0.93 yuan. As of the end of 2021 6 , the company's total assets were 61.98 .3 billion yuan, the net assets attributable to shareholders of listed companies were 46.12 .5 billion yuan, and the net assets per share were 13.40 yuan.

Cement Plate: While doing a good job in epidemic prevention and control, the cement enterprises under the company actively carry out benchmarking management and standardized management internally, continuously promote the "three reductions and three improvements" activities, strictly control production costs, steadily implement various technological transformation work, and improve the production efficiency of enterprises; timely understand market trends externally, accurately study and judge market trends, and improve sales management mode. Daye Peak has completed more than 10 technical renovation projects such as low nitrogen combustion renovation at kiln end, dust collection system renovation at kiln end, and oil station renovation of cement mill roller press, effectively reducing consumption, improving system operation rate and reducing potential environmental protection and safety hazards. Facing the market changes, the marketing strategy was adjusted in time, and the production and sales were organized in an orderly manner under the guidance of market demand. Cement sales reached a record high. Yunnan Jianfeng strictly controls the procurement cost of raw materials by strengthening bidding management and continuously tracking the dynamic price information of purchased materials; in accordance with the requirements of the quality management system, it strengthens the quality control of raw materials and semi-finished products to ensure the quality of cement factory. Relying on the advanced second-generation new dry-process cement production line and adopting digital intelligent control technology, Guizhou Huangping Jianfeng carries out all-round intelligent management of safe production, product quality, material consumption and energy consumption, environmental protection emissions, etc. Since its commissioning, various economic indicators such as standard coal consumption, electricity consumption, operation rate and kiln time production have all reached expectations. Completed the transformation of cement large packaging, frequency conversion transformation of water diversion project and other projects, and achieved results in efficiency improvement; facing the challenges of weak investment and overcapacity in the regional market, we have increased investment in brand promotion in the terminal market and further increased the share of the core market.

Pharmaceutical sector: Peak pharmaceutical products won the first bid for the national centralized procurement of drugs, olopatadine hydrochloride eye drops won the bid for the fourth batch of national centralized procurement of drugs, which is conducive to improving the market share of the product. In the first half of the year, Jianfeng Pharmaceutical and its subsidiaries made progress in a number of technological innovations and engineering constructions. The construction of the annual output of

20 .5 billion solid preparations (internationalization) project in Jinxi Production Base of Jianfeng Pharmaceutical was carried out in an orderly manner. At present, the civil engineering, mechanical and electrical installation and equipment installation and commissioning of the main project have been basically completed, and the verification and confirmation of process equipment and public system equipment and the construction of the project quality system are being carried out; new North Card and Peak North Card continue to fully implement technological transformation, upgrade on the basis of their existing pesticides and pharmaceutical intermediates, build a comprehensive research and development and production base for APIs, pharmaceutical intermediates and pesticides, and actively promote the industrial upgrading strategy of the integration of Peak Pharmaceutical APIs and preparations. Relying on the existing research and development platform and production base, Jianfeng Pharmaceutical Co., Ltd. gives full play to the enthusiasm of research and development personnel and speeds up the research and development progress of varieties under research. At present, more than 20 projects under research are in various stages of preclinical, clinical, pilot test, production declaration and consistency evaluation, and 2 projects are in Phase I clinical trials, 3 items in consistency evaluation; 2 items have been declared for production. Spike Pharmaceuticals also continues to explore new marketing business models, a comprehensive combing of product flow, and strengthen channel control.

Other sectors: Under the influence of the new coronary pneumonia epidemic, the national health care awareness is increasing, the demand for health products is gradually recovering, the peak health market expansion has achieved results, and the sales volume of health products has increased; Tianjin Peak Natural Products Company has reformed and optimized its product process, further reducing production costs while improving production capacity. Peak International Trade Phase III modern warehousing expansion project was fully delivered, warehousing and logistics business volume increased steadily, Jinhua South Station warehousing and transportation advantages into full play, warehousing and operation capacity has been improved. Peak cable by seizing the subway cable demand growth opportunities, strengthen communication with industry associations to improve visibility, to achieve revenue growth.

On the same day, the company also held the fourth meeting of the tenth board of supervisors, and reviewed and approved the company's

2021

semi-annual report and its summary and the related transaction proposal on the signing of a framework agreement for the reorganization of equity participation in subsidiaries. (residual fruit

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页